Mengting Yang

Shenzhen University

Papers

1

Total Citations

14

H-Index

1

About

Dr. Mengting Yang is a pioneering researcher at the intersection of oncology, nanotechnology, and bioengineering, whose work focuses on developing advanced platforms for targeted cancer therapy. Her most notable contribution is the design of "Janus tumor cell robots"—a groundbreaking concept that combines oncolytic adenoviruses with magnetic-driven tumor cell membranes to create active, homologous-targeting therapeutic agents. This innovative approach, detailed in her 2023 paper, enables precise virotherapy delivery to carcinoma sites, overcoming key limitations of passive drug distribution and immune evasion. Though early in her career, her work has already garnered 14 citations, signaling strong interest from the scientific community. Dr. Yang’s research holds transformative potential for personalized cancer treatment, leveraging the dual advantages of magnetic guidance and tumor cell homing to enhance therapeutic efficacy while minimizing systemic toxicity. Her achievements represent a significant step toward the next generation of intelligent, biohybrid nanorobots for active and targeted virotherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Oncolytic adenovirus-loaded magnetic-driven Janus tumor cell robots for active and targeted virotherapy of homologous carcinoma
14 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Shenzhen University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago